Coronary Stents Market Report by Type (Drug-eluting Stents, Bare-metal Coronary Stents, Bioabsorbable Stents), Biomaterial (Metallic Biomaterial, Polymeric Biomaterial, Natural Biomaterial), Mode of Delivery (Balloon-expandable Stents, Self-expanding Stents), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2024-2032
The global coronary stents market size reached US$ 11.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 18.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.46% during 2024-2032.
Coronary stents are small, self-expanding tubular metallic devices introduced inside narrow coronary arteries to keep them open after a balloon angioplasty procedure. These stents are coated with a medication, which is slowly released to prevent the walls of arteries from plaque buildup and re-narrowing. They also alleviate heart disease symptoms, such as chest pain and shortness of breath, and allow normal flow of blood and oxygen to the heart. As they are minimally invasive (MI) and require shorter recovery time, coronary stents are gaining traction over coronary artery bypass surgeries around the world.
Coronary Stents Market Trends:
The growing incidence of diabetes, obesity and high blood pressure (BP) is escalating the risk of atherosclerosis disease. This, along with the rising geriatric population, which is more likely to develop cardiovascular diseases (CVDs), represents one of the significant factors impelling the growth of the coronary stent market. Apart from this, the growing popularity of minimally invasive surgeries (MIS) is resulting in the increasing adoption of coronary stents that involve small incision wounds, short hospital stays and fast recovery. Other factors contributing to the market growth include the development of bifurcated stents, improving healthcare infrastructure and rising manufacturing of products using biodegradable materials. Furthermore, the leading market players are introducing advanced products, which is anticipated to drive the market in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global coronary stents market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, biomaterial, mode of delivery and end user.
Breakup by Type:
- Drug-eluting Stents
- Bare-metal Coronary Stents
- Bioabsorbable Stents
Breakup by Biomaterial:
- Metallic Biomaterial
- Polymeric Biomaterial
- Natural Biomaterial
Breakup by Mode of Delivery:
- Balloon-expandable Stents
- Self-expanding Stents
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical Corporation, Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Terumo Corporation and Translumina GmbH.
Key Questions Answered in This Report
1. What was the size of the global coronary stents market in 2023?
2. What is the expected growth rate of the global coronary stents market during 2024-2032?
3. What are the key factors driving the global coronary stents market?
4. What has been the impact of COVID-19 on the global coronary stents market?
5. What is the breakup of the global coronary stents market based on the type?
6. What is the breakup of the global coronary stents market based on biomaterial?
7. What is the breakup of the global coronary stents market based on the mode of delivery?
8. What is the breakup of the global coronary stents market based on the end user?
9. What are the key regions in the global coronary stents market?
10. Who are the key players/companies in the global coronary stents market?